Grants Awarded in 2010
Proteolytic Maturation of Perforin: Determining the Requirements for Cytotoxic Function
Kimberly Risma MD, PhD
Cincinnati Children’s Hospital Medical Center – Cincinnati, Ohio USA
Hybrid ImmunoTherapy (ATG/Dexamethasone/Etoposide) for Hemophagocytic Lymphohistiocytosis: The HIT-HLH Trial
Michael Jordan MD
Cincinnati Children’s Hospital Medical Center – Cincinnati, Ohio USA
The Role of BRAF V600E in the Pathogenesis of Langerhans Cell Histiocytosis
Gayane Badalian Very MD, PhD
Dana-Farber Cancer Institute – Boston, Massachusetts USA
Flow Cytometric and Secretomic Analysis of LCH Lesions
Matthew Collin MD
Institute of Cellular Medicine – Newcastle upon Tyne UK
A Gene Expression Strategy to Identifiy the Cell of Origin in Langerhans Cell Histiocytosis
Carl E. Allen MD, PhD
Texas Children’s Hospital – Houston, Texas USA
Mechanistic Studies of Defects in Lymphocyte Cytotoxicity Underlying HLH
Yenan Bryceson PhD
Center for Infectious Medicine – Stockholm, Sweden
Gene-Expression Profiling of Peripheral Blood Mononuclear Cells in Hemophagocytic Lymphohistiocytosis
Janos Sumegi MD, DSc, PhD
Cincinnati Children’s Hospital Medical Center – Cincinnati, Ohio USA
Identifying Familial Associations in Langerhans Cell Histiocytosis Using the Utah Population Database
Mark Fluchel MD
Primary Children’s Hospital – Salt Lake City, Utah USA
Histiocyte Society Clinical Trials Database System LCH-IV Treatment Protocol Study
Histiocyte Society Executive Board
LCH Study Reference Center – Vienna, Austria
Return to Grant Awards page